4 ms·
> If it works, people often _need_ it to prolong their life or improve their health. What drug companies are selling... isn’t like what other companies are sell
by AnthonyMouse 9y ago
> If it works, people often _need_ it to prolong their life or improve their health. What drug companies are selling... isn’t like what other companies are selling.
It is very much like many other products. If you don't have food you will die of starvation, if you don't have shelter you will die of exposure, etc.
The real issue is drug patents. Nobody is complaining about the price of ibuprofen any more than they complain about the price of eggs. But the patent system is doing what it's supposed to here -- twenty years ago any patented drug didn't exist, and it nominally only exists now because the inventors judged it to be sufficiently profitable to conduct the research. If you make it less profitable, you'll get less research.
There is no drug research fairy. If you don't want the money to come from high insurance premiums that pay for high drug costs, it has to come from somewhere else. And just devising some other method (like taxes) of extracting the same money from the same general public isn't really going to change much.
- mikeash 9y agoPharmaceutical R&D spending isn’t all that high. It’s around $300 per capita in the US. The money is not coming from high insurance premiums.
- pg_bot 9y agoThat is around 90 Billion dollars. I'm not sure where you got that number exactly, but phrma member companies list their combined 2016 R&D expenditures at 65.3 billion[0] so it seems plausible. For context that is around the GDP of Slovakia or Sri Lanka. (65th and 66th biggest world economies)[1] [0] https://www.phrma.org/press-release/randd-investment-by-u-s-biopharmaceutical-companies-remains-strong-despite-ongoing-economic-challenges https://www.phrma.org/press-release/randd-investment-by-u-s-... [1] https://en.wikipedia.org/wiki/List_of_countries_by_GDP_(nominal) https://en.wikipedia.org/wiki/List_of_countries_by_GDP_(nomi...
- mikeash 9y agoI don’t understand how comparing it to the GDP of small foreign countries adds context. The important context is what I stated: it’s about $300 per person. That means that it’s a very small portion of our ~$10,000/year per capita health care expenditures. Anyone who knows how much their health insurance costs per year can immediately see how much of that funds their share of pharma R&D. The answer will almost always be “not very much.”
- rayiner 9y agoPharmaceutical expenditures are about $1,000 per capita. Turning $1,000 of revenue into $300 in R&D compares very favorably to other tech industries.
- kirubakaran 9y agoAccording to https://en.wikipedia.org/wiki/List_of_countries_by_total_health_expenditure_per_capita https://en.wikipedia.org/wiki/List_of_countries_by_total_hea... it is close to $10k, not $1k.
- AnthonyMouse 9y agoThat is total healthcare expenditures including things like doctor/nurse/lab tech salaries, medical devices, administrative overhead, etc. The amount spent on pharma is ~$1K per capita.
- mikeash 9y agoI’m not sure how that’s related. My point is that pharma R&D is not a significant cause of high insurance premiums or high health care costs in general.
- AnthonyMouse 9y ago> My point is that pharma R&D is not a significant cause of high insurance premiums or high health care costs in general. It's the same issue across the industry. There are patents on medical devices, diagnostic tests, imaging equipment, etc. It's a major source of costs. And nobody is claiming that it's the only one.
- peterashford 9y agoBut drugs are produced in other countries, too, and they manage to do so without charging what US companies do.
- AnthonyMouse 9y ago> But drugs are produced in other countries, too, and they manage to do so without charging what US companies do. It's a global market. Companies can develop drugs in other countries and recover a sizable chunk of their investment by selling in the US market. In other words, the other countries aren't paying their fair share of the research costs, and that is causing a global underinvestment in medical research.
- dagw 9y agoThose companies charge exactly the same as the US companies when selling to the US. Much like US companies charge the same as European companies when selling to Europe.
- pwinnski 9y agoIf you don't have food, you will die of starvation. You don't need one particular food that is only available from one manufacturer. Not the same at all.
- d0lph 9y agoI think patents are anti-capitalistic, perhaps we should just get rid of them.